|
|
||||||||
The Journal of Immunology, Vol 150, Issue 2 556-562, Copyright © 1993 by American Association of Immunologists
ARTICLES |
JW Coleman, MR Holliday, I Kimber, KM Zsebo and SJ Galli
Department of Pharmacology and Therapeutics, University of Liverpool, United Kingdom.
We examined whether three cytokines that promote mouse mast cell development, the c-kit ligand stem cell factor (SCF), IL-3, or IL-4, also can directly stimulate or modulate mouse peritoneal mast cell (PMC) mediator release. Challenge of purified PMC with rat rSCF164 at 20 to 100 ng/ml for 30 min induced a modest release of serotonin (5- HT), whereas IL-3 or IL-4 did not directly stimulate 5-HT release. Experiments in which PMC were exposed to each cytokine for 15 min, and then to DNP-HSA Ag or anti-IgE antibody for a further 15 min, showed that SCF, but not IL-3 or IL-4, had an additive effect on the 5-HT release induced by either of the IgE cross-linking agents. In longer term experiments, SCF (0.16 to 500 ng/ml), IL-3 (2.5 to 100 ng/ml), or IL-4 (0.06 to 2.5 ng/ml) was added to peritoneal cell cultures for 48 h, during which the cells were passively sensitized with IgE anti-DNP antibody. Incubation of either unfractionated or highly purified PMC preparations with each of the three cytokines resulted in a concentration-related increase in 5-HT release upon subsequent challenge of the cells with DNP-HSA Ag. However, after pretreatment of peritoneal cells for 48 h with each cytokine, only IL-4 (10 ng/ml) enhanced release of 5-HT induced by calcium ionophore A23187 (0.25 microM); IL-3 (100 ng/ml) had no effect, whereas SCF (100 ng/ml) significantly inhibited ionophore-induced release. Although IL-3 or SCF up-regulate responsiveness to IgE-dependent stimuli, we detected no effect of these cytokines on the binding of [125I]IgE to PMC. This suggests that the enhancing effects of SCF or IL-3 on IgE-dependent 5- HT release did not simply reflect changes in the amount of IgE bound to the cells. In conclusion, we found that SCF, IL-3, or IL-4 each exerted a different spectrum of stimulatory, costimulatory, or regulatory effects on the secretory function of mouse PMC.
This article has been cited by other articles:
![]() |
J Wang and M Hauer-Jensen Neuroimmune interactions: potential target for mitigating or treating intestinal radiation injury Br. J. Radiol., September 1, 2007; 80(Special_Issue_1): S41 - S48. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Li, J. Berman, J.-T. Tang, and T.-J. Lin The Early Growth Response Factor-1 Is Involved in Stem Cell Factor (SCF)-induced Interleukin 13 Production by Mast Cells, but Is Dispensable for SCF-dependent Mast Cell Growth J. Biol. Chem., August 3, 2007; 282(31): 22573 - 22581. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. Hsieh, P. Sharma, A. Gibbons, T. Goggans, S. C. Erzurum, and S. J. Haque Human airway epithelial cell determinants of survival and functional phenotype for primary human mast cells PNAS, October 4, 2005; 102(40): 14380 - 14385. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sawada, S. Shimizu, T. Tamatani, S. Kanegasaki, H. Saito, A. Tanaka, N. Kambe, T. Nakahata, and H. Matsuda Stem Cell Factor Has a Suppressive Activity to IgE-Mediated Chemotaxis of Mast Cells J. Immunol., March 15, 2005; 174(6): 3626 - 3632. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gessner, K. Mohrs, and M. Mohrs Mast Cells, Basophils, and Eosinophils Acquire Constitutive IL-4 and IL-13 Transcripts during Lineage Differentiation That Are Sufficient for Rapid Cytokine Production J. Immunol., January 15, 2005; 174(2): 1063 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Hundley, A. M. Gilfillan, C. Tkaczyk, M. V. Andrade, D. D. Metcalfe, and M. A. Beaven Kit and Fc{epsilon}RI mediate unique and convergent signals for release of inflammatory mediators from human mast cells Blood, October 15, 2004; 104(8): 2410 - 2417. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Coward, Y. Okayama, H. Sagara, S. J. Wilson, S. T. Holgate, and M. K. Church NF-{kappa}B and TNF-{alpha}: A Positive Autocrine Loop in Human Lung Mast Cells? J. Immunol., November 1, 2002; 169(9): 5287 - 5293. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhang, G. Stoica, S. I. Tasca, K. A. Kelly, and C. J. Meininger Modulation of Tumor Angiogenesis by Stem Cell Factor Cancer Res., December 1, 2000; 60(23): 6757 - 6762. [Abstract] [Full Text] |
||||
![]() |
C. L. Bone-Larson, C. M. Hogaboam, M. L. Steinhauser, S. H. P. Oliveira, N. W. Lukacs, R. M. Strieter, and S. L. Kunkel Novel Protective Effects of Stem Cell Factor in a Murine Model of Acute Septic Peritonitis : Dependence on MCP-1 Am. J. Pathol., October 1, 2000; 157(4): 1177 - 1186. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Brooks, D. M. Briggs, N. C. Eastmond, D. G. Fernig, and J. W. Coleman Presentation of IFN-{gamma} to Nitric Oxide-Producing Cells: A Novel Function for Mast Cells J. Immunol., January 15, 2000; 164(2): 573 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. BURCHARD, E. K. SILVERMAN, L. J. ROSENWASSER, L. BORISH, C. YANDAVA, A. PILLARI, S. T. WEISS, J. HASDAY, C. M. LILLY, J. G. FORD, et al. Association Between a Sequence Variant in the IL-4 Gene Promoter and FEV1 in Asthma Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 919 - 922. [Abstract] [Full Text] |
||||
![]() |
M. Yamaguchi, K. Sayama, K. Yano, C. S. Lantz, N. Noben-Trauth, C. Ra, J. J. Costa, and S. J. Galli IgE Enhances Fc{epsilon} Receptor I Expression and IgE-Dependent Release of Histamine and Lipid Mediators from Human Umbilical Cord Blood-Derived Mast Cells: Synergistic Effect of IL-4 and IgE on Human Mast Cell Fc{epsilon} Receptor I Expression and Mediator Release J. Immunol., May 1, 1999; 162(9): 5455 - 5465. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Ryan, S. DeSimone, G. Klisch, C. Shelburne, L. J. McReynolds, K. Han, R. Kovacs, P. Mirmonsef, and T. F. Huff IL-4 Inhibits Mouse Mast Cell Fc{epsilon}RI Expression Through a STAT6-Dependent Mechanism J. Immunol., December 15, 1998; 161(12): 6915 - 6923. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Biro, M. Maurer, S. Modarres, N. E. Lewin, C. Brodie, G. Acs, P. Acs, R. Paus, and P. M. Blumberg Characterization of Functional Vanilloid Receptors Expressed by Mast Cells Blood, February 15, 1998; 91(4): 1332 - 1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Dvorak, J. J. Costa, E. S. Morgan, R. A. Monahan-Earley, and S. J. Galli Diamine Oxidase-Gold Ultrastructural Localization of Histamine in Human Skin Biopsies Containing Mast Cells Stimulated to Degranulate In Vivo by Exposure to Recombinant Human Stem Cell Factor Blood, October 15, 1997; 90(8): 2893 - 2900. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gagari, M. Tsai, C. S. Lantz, L. G. Fox, and S. J. Galli Differential Release of Mast Cell Interleukin-6 Via c-kit Blood, April 15, 1997; 89(8): 2654 - 2663. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamaguchi, C. S. Lantz, H. C. Oettgen, I. M. Katona, T. Fleming, I. Miyajima, J.-P. Kinet, and S. J. Galli IgE Enhances Mouse Mast Cell Fcepsilon RI Expression In Vitro and In Vivo: Evidence for a Novel Amplification Mechanism in IgE-dependent Reactions J. Exp. Med., February 17, 1997; 185(4): 663 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Samet, M. B. Fasano, A. N. Fonteh, and F. H. Chilton Selective Induction of Prostaglandin G/H Synthase I by Stem Cell Factor and Dexamethasone in Mast Cells J. Biol. Chem., April 7, 1995; 270(14): 8044 - 8049. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Murakami, R. Matsumoto, Y. Urade, K. F. Austen, and J. P. Arm c-Kit Ligand Mediates Increased Expression of Cytosolic Phospholipase A(2), Prostaglandin Endoperoxide Synthase-1, and Hematopoietic Prostaglandin D(2) Synthase and Increased IgE-dependent Prostaglandin D(2) Generation in Immature Mouse Mast Cells J. Biol. Chem., February 17, 1995; 270(7): 3239 - 3246. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |